Source: MarketScreener

D.O.R.C.: Eurazeo: finalizes sale of DORC

(marketscreener.com) Eurazeo finalizes the sale of Dutch Ophthalmic Research Center to Carl Zeiss Meditec, one of the world's leading medical technology companies. DORC is a leading and fast-growing ophthalmic surgery platform in the vitreoretina and cataract markets. Eurazeo has supported DORC's growth, consolidating its sector expertise and accelerating its...https://www.marketscreener.com/quote/stock/EURAZEO-SE-4643/news/Eurazeo-finalizes-sale-of-DORC-46351532/?utm_medium=RSS&utm_content=20240403

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Pierre Billardon's photo - CEO of D.O.R.C.

CEO

Pierre Billardon

CEO Approval Rating

90/100

Read more